NEW YORK (GenomeWeb) – Sophia Genetics announced today that it has closed a $15 million Series C financing round led by Belgian billionaire Marc Coucke, the founder of Omega Pharma.

The Swiss genetics company will use the funds to add to its line of genomic tests and continue expanding its market, it said in a statement. Sophia added that it has seen a 400 percent growth rate in 2015, led by its analytics platform, Sophia Data Driven Medicine.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.